What are the recommendations for IV alteplase administration in patients with end-stage renal disease?
In patients with end-stage renal disease on hemodialysis and normal aPTT, IV alteplase is recommended. (COR I; LOE C-LD) However, those with elevated aPTT may have elevated risk for hemorrhagic complications.